Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000748

Chief Discovery/Trans Medicine sold 38,443 shares at an average $34.69 ($1,333,529)

  • Chief Discovery/Trans Medicine acquired 75,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hamilton James C · Chief Discovery/Trans Medicine

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-03 Sale : show line 1 in the form 10b5-1 −3,500 $31.81 $111,335 178,734 D
2024-01-03 Sale : show line 2 in the form 10b5-1 −2,300 $32.52 $74,796 176,434 D
2024-01-03 Sale : show line 3 in the form 10b5-1 −500 $33.30 $16,650 175,934 D
2024-01-04 Grant or award : show line 4 in the form 10b5-1 +75,000 250,934 D
2024-01-05 Sale : show line 5 in the form 10b5-1 −1,800 $34.00 $61,200 249,134 D
2024-01-05 Sale : show line 6 in the form 10b5-1 −8,000 $34.94 $279,520 241,134 D
2024-01-05 Sale : show line 7 in the form 10b5-1 −12,343 $35.65 $440,028 228,791 D
2024-01-05 Sale : show line 8 in the form 10b5-1 −10,000 $35.00 $350,000 218,791 D
Open-market sales · 38,443 sh · avg $34.69 · $1,333,529
Loading xslF345X05/wk-form4_1704502965.xml…